Regulatory Environment for HIV/AIDS in the US Product Launches Strategic Corporate Developments Focus on Key Players 3M Abbott Laboratories Amazon Biotech## Bristol-Myers Squibb FermaVir Pharmaceuticals Gilead Sciences Hemispherx Biopharma MedImmune Inc. Merck & Co. Novartis Pharmaceuticals Novelos Therapeutics Panacos Pharmaceuticals Pfizer Inc. Pharmasset Schering-Plough Corporation <A HREF="http://pharmalicensing.com/intelligence/reportsearching.php?action=toc&productID=1389772" target="_blank">http://pharmalicensing.com/intelligence/reportsearching.php?action=toc&productID=1389772</A>